Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.
- DOI
- 10.3389/fimmu.2022.839945
- Published
- 2022
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2022.839945,
title = {Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.},
author = {Shomali N and Suliman Maashi M and Baradaran B and Daei Sorkhabi A and Sarkesh A and Mohammadi H and Hemmatzadeh M and Marofi F and Sandoghchian Shotorbani S and Jarahian M},
year = {2022},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2022.839945},
url = {https://doi.org/10.3389/fimmu.2022.839945}
}RIS
TY - JOUR TI - Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies. AU - Shomali N AU - Suliman Maashi M AU - Baradaran B AU - Daei Sorkhabi A AU - Sarkesh A AU - Mohammadi H AU - Hemmatzadeh M AU - Marofi F AU - Sandoghchian Shotorbani S AU - Jarahian M PY - 2022 JO - Frontiers in immunology DO - 10.3389/fimmu.2022.839945 UR - https://doi.org/10.3389/fimmu.2022.839945 ER -
APA
N, S., M, S. M., B, B., A, D. S., A, S., H, M., M, H., F, M., S, S. S., & M, J. (2022). Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.839945
Source records
- pubmed · retrieved 2026-09-25T04:17:48.722Z